Juniper Pharma (JNP) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Citi names 5 top chip picks ahead of Q3 earnings
Tweet
Share
E-mailGet Alerts JNP Hot Sheet
Join SI Premium – FREE
Juniper Pharma (NASDAQ: JNP) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $13 million versus the consensus estimate of $12.55 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
